There are multiple bear arguments floating around as reasons to sell Moderna (NASDAQ: MRNA), one of the drugmakers leading the way to develop a coronavirus vaccine.
Most of them don't hold much water.
Image source: Getty Images.
Source Fool.com
There are multiple bear arguments floating around as reasons to sell Moderna (NASDAQ: MRNA), one of the drugmakers leading the way to develop a coronavirus vaccine.
Most of them don't hold much water.
Image source: Getty Images.
Source Fool.com